Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|
12:05-12:10 |
Welcome Speech
Gao-Jun Teng
Zhongda Hospital, Southeast University, China
|
||
12:10-12:15 |
Welcome Speech
Lisa X. Xu
Shanghai Jiao Tong University, China
|
||
12:15-12:30 |
Present Status And Prospect —— Clinical Application Of Multi-mode Thermal Therapy |
Wen-Tao Li | Fudan University Shanghai Cancer Center, China |
12:30-12:45 |
Progress And Prospect of Study on Mechanism Of Multi-mode Thermal Immune Therapy |
Ping Liu | Shanghai Jiao Tong University, China |
12:45-13:05 |
Review Comments And Interactive Q&A
Xiao-Yi Ding
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China /
Ji-Jin Yang
Changhai Hospital Affiliated to Naval Medical University, China /
Jian-Song Ji
Lishui Municipal Central Hospital, China /
Hai-Bo Shao
The First Affiliated Hospital of China Meical University, China /
Hai-Dong Zhu
Zhongda Hospital, Southeast University, China
|
Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|
13:30-13:42 |
RFA for lung meta |
Koichiro Yamakado | Hyogo Medical University, Japan |
13:42-13:54 |
Tansarterial chemoembolization for primary lung cancer |
Feng Duan | PLA General Hospital, China |
13:54-14:06 |
Pulmonary ablation beyond RFA |
Roberto Iezzi | Università Cattolica del Sacro Cuore, Italy |
14:06-14:18 |
Translational research on early diagnosis and early treatment of lung cancer |
Wen-Hua Liang | The First affiliated Hospital of Guangzhou Medical University, China |
14:18-14:30 |
Transbronchial microwave ablation of lung tumors: state of the art |
Calvin Sze Hang Ng | Prince of Wales Hospital, Hong Kong, China |
14:30-14:42 |
Opportunities and challenges of robotic surgical systems after downstaging and conversion in the era of immunotherapy |
Jian Hu | The First Affiliated Hospital Zhejiang University, China |
14:42-14:54 |
Advances of immunotherapy for lung cancer |
Jie Wang | Cancer Hospital Chinese Academy of Medical Sciences, China |
14:54-15:15 |
Q & A |
Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|
15:30-15:42 |
Progress in surgical management of intrahepatic cholangiocarcinoma |
Feng Shen | Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China |
15:42-15:54 |
Balloon-occlusion for liver embolotherapy: Is there a benefit over traditional microcatheters? |
David C. Madoff | Yale School of Medicine, USA |
15:54-16:06 |
Surgical cure and functional preservation for colorectal cancer patients ----the procedures and scientific evidence for LISH |
Ke-Feng Ding | The Second Affiliated Hospital of Zhejiang University School of Medicine, China |
16:06-16:18 |
Modified BRTO procedures for portal hypertension |
Hyun Ki Yoon | Asan Medical Center, University of Ulsan College of Medicine, Korea |
16:18-16:30 |
Needs assessment of next generation embolics used in oncology |
David M. Liu | Vancouver General Hospital, Canada |
16:30-16:42 |
Hepatic plexus nerve block for liver ablation |
Edward W. Lee | David Geffen School of Medicine at UCLA, USA |
16:42-16:54 |
Advances of systemic therapy for colorectal cancer with liver metastasis |
Zhi-Yu Chen | Fudan University Shanghai Cancer Center, China |
16:54-17:06 |
PTBD for obstructing tumors of the pancreas and bile duct |
Manuel Zeledón | University of Costa Rica, Costa Rica |
17:06-17:18 |
Metastastic Deficient Mismatch Repair Colorectal Cancer:From palliative to cure through systemic therapy |
Yan-Hong Deng | The Sixth Affiliated Hospital of Sun Yat-sen University, China |
17:18-17:30 |
Techniques and status of hepatic arterial infusion chemotherapy in cholangiocarcinoma |
Xiao-Dong Wang | Beijing Cancer Hospital, China |
17:30-17:40 |
Q & A |